In silico validation of a new classifier, PCSCGier, for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.1105 |